October retail sales land this morning into the most yield-hostile backdrop stocks have faced all year.
October retail sales grew only 0.4% despite the National Day holiday. Investors now have to decide whether...
FDA rejection of Summit’s ivonescimab tests the case for in-licensed Chinese cancer drugs.
NGS ARR up 63%, CyberArk closed, stock 25% off its high. Q1 FY2027 drops Wednesday.
A California lawsuit seeks to freeze frontier AI development days before Anthropic begins trading on Nasdaq.
With the 10-year Treasury near 5.15% and December hike odds near 90%, the S&P 500 at 7,561...
A record first-half profit and a ¥200bn buyback show a shift in shareholder returns.
Trump’s Iran stance and Houthi strikes near Yanbu reset the energy board. Valero and Marathon are the...
With $33.2 billion in nine-month revenue and a $104 billion net loss on the books, the ANT...
Spot gold is near $3,960 and COMEX futures around $3,975 after a two-day drop. Silver is near...
